Healthcare company-building profile
Unreasonable Impact
Unreasonable Group with Barclays
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Government or nonprofit accelerator
- Organization
- Unreasonable Group with Barclays
- Organization type
- Nonprofit
- Location
- Boulder, Colorado
- Company stage served
- Growth stage
- Cohort or participation model
- Intensive multi-day residential programs for growth-stage companies with ongoing lifetime network access; regional programs including an Americas cohort
- Investment or funding offered
- Yes
- Published investment terms
- Non-dilutive; accelerator participation is provided without taking equity, with separate affiliated investment vehicles
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2016
Public description
About the program
Unreasonable Impact is a growth-stage accelerator run by Unreasonable Group in partnership with Barclays, supporting entrepreneurs scaling solutions to global challenges including health and wellbeing. Selected companies join intensive residential programs with mentorship from a large network of investors, executives and experts, and retain lifetime access to the Unreasonable network. Unreasonable Group is a certified B Corporation and also operates Unreasonable Ventures and Unreasonable Capital.
What the program publicly emphasizes
Focus areas and features
- Category: Government or nonprofit accelerator
- Program structure: Intensive multi-day residential programs for growth-stage companies with ongoing lifetime network access; regional programs including an Americas cohort
- Published terms: Non-dilutive; accelerator participation is provided without taking equity, with separate affiliated investment vehicles
Publicly documented people and network
Program leadership and alumni
- Program leader
- Daniel Epstein — Founder
Sources
External source links open in a new tab.